Stifel analyst David Grossman lowered the price target on OptimizeRX (NASDAQ: OPRX) to $14.00 (from $17.00) while maintaining a Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE